FDA approves new drug to treat major depressive disorder
The U.S. Food and Drug Administration today approved Brintellix (vortioxetine) to treat adults with major depressive disorder.
-
Subscribe
Subscribe via the RSS feed
The U.S. Food and Drug Administration today approved Brintellix (vortioxetine) to treat adults with major depressive disorder.